Browse
Submit Data
Databases
API
Help

Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

SiRNA-mediated knockdown of RUVBL1 and RUVBL2 in CLB-BAR neuroblastoma cells

ABSTRACT: To investigate the role of RUVBL1/2 in neuroblastoma, we performed siRNA-mediated knockdown of RUVBL1 and RUVBL2 in CLB-BAR cells. Cells were transfected with Silencer Select siRNAs (Life Technologies) targeting RUVBL1 (ID S16369 and S16370) or RUVBL2 (ID S21307 and S21309) or a non-targeting scrambled control siRNA (S103650325, Qiagen), using Lipofectamine RNAiMAX, then cultured for 72 hours before RNA extraction and sequencing.

INSTRUMENT(S): Illumina NovaSeq X

ORGANISM(S): Homo sapiens

SUBMITTER: Arne Claeys

PROVIDER: E-MTAB-16403 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

ACCESS DATA

Json Xml

Similar Datasets

siRNA-mediated knockdown of RUVBL1 and RUVBL2 in CLB-BAR neuroblastoma cells

Project description:siRNA-mediated knockdown of RUVBL1 and RUVBL2 in CLB-BAR neuroblastoma cells

| PRJEB105556 | ENA

Transcriptomic profiling of three different neuroblastoma cell lines (CLB-BAR, CLB-GE and SK-N-AS) in response to ALK inhibition

Project description:Anaplastic Lymphoma Kinase (ALK) is a tyrosine kinase receptor which is a clinical target of major interest in cancer, including neuroblastoma. To better understand ALK signaling, three different neuroblastoma cell lines (CLB-BAR, CLB-GE and SK-N-AS) were cultured for 1hr and 24hrs in control conditions or after treatment with the ALK inhibitors crizotinib or lorlatinib. RNA-Seq experiments were performed to determine the expression changes resulting from ALK inhibition. Together with parallel phosphoproteomic experiments, these data unveil several important conserved oncogenic pathways in neuroblastoma.

2018-09-01 | E-MTAB-6654 | biostudies-arrayexpress

Transcriptomic profiling of three different neuroblastoma cell lines (CLB-BAR, CLB-GE and SK-N-AS) in response to ALK inhibition

Project description:Transcriptomic profiling of three different neuroblastoma cell lines (CLB-BAR, CLB-GE and SK-N-AS) in response to ALK inhibition

| PRJEB26451 | ENA

Single cell RNA-Seq of Neuroblastoma cell line (CLB-berlud)

Project description:We report the application of single-molecule-based sequencing technology for high-throughput profiling of Neuroblastoma cell line (CLB-berlud) Examination of gene expression in Neuroblastoma cell line (CLB-berlud), as a negative control

2020-02-14 | GSE130022 | GEO

High-throughput high-multiplexed screening for splicing factors

Project description:An arrayed library containing pooled siRNAs targeting 18,480 human genes (Dharmacon, Lafayette, CO) was screened as previously described (Roosing et al., 2015).Briefly, 384-well plates with optical bottom (Greiner Bio-One, Monroe, NC) were spotted with 1 μl of 0.5 μM siRNA. Reverse transfection was next performed using Lipofectamine RNAiMAX at the final siRNA concentration of 10 nM. Culture medium was replaced with DMEM 24 hrs after transfection and cells were incubated for additional 48 hrs before lysis in SDS buffer for downstream analysis. These siRNAs were distributed in 57 plates, and after screen, we pooled 4 bar-coded plates for sequencing per Illumina sequencing lane.

2022-07-01 | GSE207344 | GEO

Trypanosoma cruzi CLB vs Trypanosoma rangeli and Trypanosoma conorhini

Project description:Comparative genomic analysis of T. cruzi CLB vs Trypanosoma rangeli (strains SC, Choachí, C23, H14, R1625 and PIT10) and Trypanosoma conorhini

2023-04-11 | GSE229354 | GEO

RNA-seq of CLB-GA neuroblastoma cell line upon TBX2 knockdown

Project description:RNA-seq upon TBX2 knockdown in the neuroblastoma cell line CLB-GA. Cells were transduced with two different shRNAs (sh#2 and sh#4) targeting TBX2 and a non-targeting control (NTC), and selected with puromycin. Analysis was performed seven days upon TBX2 knockdown, including three biological replicates per condition.

2018-08-16 | E-MTAB-6567 | biostudies-arrayexpress

Transcriptome profiling of human anaplastic meningioma IOMM-Lee cells following silencing of HuR (Human antigen R) gene expression by siRNA

Project description:The human anaplastic meningioma IOMM-Lee cells were cultured in Dulbeccoâs modified Eagleâs medium (Life Technologies, Carlsbad, California, USA) supplemented with 10% fetal bovine serum, 100 U/ml penicillin, and 100 mg/ml streptomycin, at 37Â°C in 20% O2 (5% CO2). HuR silencing was achieved by transfecting cells in a 96 well-plate with 500 Âµl per well of culture medium containing 10 Âµl of siRNA (Silencer Select siRNA ELAVL1 s4608; Ambion, Life Technologies; 1 Âµmol/L),1 ÂµL of RNAiMAX lipofectamin and 89 ÂµL of opti-MEM (Life Technologies). Negative control cells were obtained under the same conditions using the Silencer Select Negative Control siRNA#1 (Ambion, Life Technologies). All assays were performed in sextaplicates.

2017-07-01 | E-MTAB-4999 | biostudies-arrayexpress

RNA-seq of human CLB-GA and NGP neuroblastoma cell lines with SOX11 knockdown as compared to control

Project description:RNA-seq upon SOX11 knockdown in the neuroblastoma cell lines CLB-GA and NGP. Cells were nucleofected with a pool of four different siRNAs targeting SOX11 and a non-targeting control (NTC). Analysis was performed 2 days upon SOX11 knockdown, including four biological replicates per condition.

2022-12-13 | E-MTAB-11883 | biostudies-arrayexpress

Wairau Bar

Project description:Wairau Bar human mitochondrial genome sequences

| PRJEB550 | ENA